Vimarsana
Biggest News Aggregation in the World

Page 47 - Shannon Devine News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shannon Devine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shannon Devine Today - Breaking & Trending Today

UPHEALTH ANNOUNCES CLOSING OF $67.5 MILLION CONVERTIBLE DEBT FINANCING - Vimarsana News

UPHEALTH ANNOUNCES CLOSING OF $67.5 MILLION CONVERTIBLE DEBT FINANCING

/PRNewswire/ -- UpHealth, Inc. ("UpHealth" or the "Company") (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and...

UPHEALTH ANNOUNCES CLOSING OF $67.5 MILLION CONVERTIBLE DEBT FINANCING - Vimarsana News

UPHEALTH ANNOUNCES CLOSING OF $67.5 MILLION CONVERTIBLE DEBT FINANCING

/PRNewswire/ -- UpHealth, Inc. ("UpHealth" or the "Company") (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and...

Ensysce Biosciences, Inc.: Ensysce Biosciences Releases Updated Investor Presentation Ahead of Corporate Update Call - Vimarsana News

Ensysce Biosciences, Inc.: Ensysce Biosciences Releases Updated Investor Presentation Ahead of Corporate Update Call

~ Call to be Held Today, August 17, 2022 at 11am ET ~SAN DIEGO, CA / ACCESSWIRE / August 17, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage

Tenon Medical, Inc. Reports Second Quarter 2022 Financial Results - Vimarsana News

Tenon Medical, Inc. Reports Second Quarter 2022 Financial Results

~ Revenue increases 514% year-over-year ~~ 21 physician workshop events completed ~LOS GATOS, CA/ ACCESSWIRE / August 11, 2022 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a

Ensysce Biosciences, Inc.: Ensysce Biosciences Provides Business Update and Reports Second Quarter 2022 Financial Results - Vimarsana News

Ensysce Biosciences, Inc.: Ensysce Biosciences Provides Business Update and Reports Second Quarter 2022 Financial Results

Corporate Update Call to be Held Wednesday, August 17, 2022SAN DIEGO, CA / ACCESSWIRE / August 11, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC, OTC PINK:ENSCW), a clinical-stage